Dimensional Fund Advisors LP raised its position in shares of Agilent Technologies Inc (NYSE:A) by 0.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 878,200 shares of the medical research company’s stock after buying an additional 7,349 shares during the period. Dimensional Fund Advisors LP owned about 0.27% of Agilent Technologies worth $54,305,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brinker Capital Inc. raised its stake in shares of Agilent Technologies by 14.2% in the first quarter. Brinker Capital Inc. now owns 6,334 shares of the medical research company’s stock valued at $424,000 after acquiring an additional 788 shares in the last quarter. Advisor Partners LLC raised its stake in shares of Agilent Technologies by 8.8% in the second quarter. Advisor Partners LLC now owns 9,932 shares of the medical research company’s stock valued at $614,000 after acquiring an additional 803 shares in the last quarter. Schroder Investment Management Group raised its stake in shares of Agilent Technologies by 1.9% in the first quarter. Schroder Investment Management Group now owns 44,623 shares of the medical research company’s stock valued at $2,985,000 after acquiring an additional 831 shares in the last quarter. IFM Investors Pty Ltd raised its stake in shares of Agilent Technologies by 9.2% in the first quarter. IFM Investors Pty Ltd now owns 9,954 shares of the medical research company’s stock valued at $666,000 after acquiring an additional 837 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its stake in shares of Agilent Technologies by 2.0% in the first quarter. Nomura Asset Management Co. Ltd. now owns 45,401 shares of the medical research company’s stock valued at $3,038,000 after acquiring an additional 895 shares in the last quarter.

Agilent Technologies stock opened at $70.38 on Wednesday. Agilent Technologies Inc has a 1-year low of $60.42 and a 1-year high of $75.00. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.00 and a current ratio of 3.62. The firm has a market capitalization of $22.54 billion, a price-to-earnings ratio of 29.94, a price-to-earnings-growth ratio of 2.43 and a beta of 1.36.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, August 14th. The medical research company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.04. Agilent Technologies had a return on equity of 18.61% and a net margin of 6.20%. The company had revenue of $1.20 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period last year, the firm earned $0.59 earnings per share. Agilent Technologies’s quarterly revenue was up 8.0% on a year-over-year basis. analysts anticipate that Agilent Technologies Inc will post 2.71 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 24th. Shareholders of record on Tuesday, October 2nd will be paid a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date is Monday, October 1st. Agilent Technologies’s dividend payout ratio is presently 25.42%.

In other news, Director Heidi Fields sold 5,482 shares of Agilent Technologies stock in a transaction dated Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total transaction of $371,295.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Paul N. Clark sold 2,876 shares of Agilent Technologies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $68.60, for a total value of $197,293.60. The disclosure for this sale can be found here.

Several analysts have recently issued reports on A shares. Deutsche Bank increased their price objective on Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, August 15th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research note on Tuesday, August 7th. ValuEngine upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, July 25th. Goldman Sachs Group reiterated a “buy” rating and issued a $82.00 price objective (up from $77.00) on shares of Agilent Technologies in a research note on Tuesday, September 18th. Finally, Morgan Stanley increased their price objective on Agilent Technologies from $83.00 to $84.00 and gave the company an “overweight” rating in a research note on Wednesday, August 15th. Ten investment analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and an average price target of $77.22.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Understanding Analyst Ratings

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.